PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9238754-5	1997	Further, treatment of tumour-bearing mice with histamine enhances IL-2- and IFN-alpha-induced destruction of NK cell-sensitive tumour cells in vivo.	Histamine	47-56	interferon alpha	Mus musculus	76-85	
11836621-2	2002	Histamine thus reverses negative regulation of NK cells treated with IL-2 and IFN-alpha in the presence of macrophages.	Histamine	0-9	interferon alpha	Mus musculus	78-87	
8560202-5	1996	Histamine potentiated the anti-tumour properties of NK-cell activators such as interleukin-2 (IL-2) or interferon-alpha (IFN-alpha) in vivo.	Histamine	0-9	interferon alpha	Mus musculus	103-119	
8560202-5	1996	Histamine potentiated the anti-tumour properties of NK-cell activators such as interleukin-2 (IL-2) or interferon-alpha (IFN-alpha) in vivo.	Histamine	0-9	interferon alpha	Mus musculus	121-130